Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer
Author:
Affiliation:
1. Conju-probe, San Diego, California, USA
2. Bharath University, Chennai, Tamil Nadu, 600126, India
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Reference20 articles.
1. Zhang S.S.; Nagasaka M.; Spotlight on sotorasib (AMG 510) for KRASG12C positive non-small cell lung cancer. Lung Cancer (Auckl) 2021,12,115-122
2. Hong D.S.; Fakih M.G.; Strickler J.H.; Desai J.; Durm G.A.; Shapiro G.I.; Falchook G.S.; Price T.J.; Sacher A.; Denlinger C.S.; Bang Y.J.; Dy G.K.; Krauss J.C.; Kuboki Y.; Kuo J.C.; Coveler A.L.; Park K.; Kim T.W.; Barlesi F.; Munster P.N.; Ramalingam S.S.; Burns T.F.; Meric-Bernstam F.; Henary H.; Ngang J.; Ngarmchamnanrith G.; Kim J.; Houk B.E.; Canon J.; Lipford J.R.; Friberg G.; Lito P.; Govindan R.; Li B.T.; KRAS G12C inhibition with sotorasib in advanced solid tumors. N Engl J Med 2020,383(13),1207-1217
3. Canon J.; Rex K.; Saiki A.Y.; Mohr C.; Cooke K.; Bagal D.; Gaida K.; Holt T.; Knutson C.G.; Koppada N.; Lanman B.A.; Werner J.; Rapaport A.S.; San Miguel T.; Ortiz R.; Osgood T.; Sun J.R.; Zhu X.; McCarter J.D.; Volak L.P.; Houk B.E.; Fakih M.G.; O’Neil B.H.; Price T.J.; Falchook G.S.; Desai J.; Kuo J.; Govindan R.; Hong D.S.; Ouyang W.; Henary H.; Arvedson T.; Cee V.J.; Lipford J.R.; The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 2019,575(7781),217-223
4. Sproat M.R.; Hofherr M.L.; Devarakonda S.; Successful use of sotorasib in a patient with end stage renal disease on dialysis with metastatic lung adenocarcinoma: A case report. Clin Lung Cancer 2022,23(6),E339-E341
5. Ganguly A.; Yoo E.; Sotorasib: A KRASG12C inhibitor for non-small cell lung cancer. Trends Pharmacol Sci 2022,43(6),536-537
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm;Current Gene Therapy;2025-04
2. Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP;European Journal of Pharmacology;2023-12
3. In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer;Molecular Simulation;2023-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3